About Agency for Science, Technology and Research (A*STAR)A*STAR is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society.About the Singapore Bioimaging Consortium (SBIC)The Singapore Bioimaging Consortium (SBIC) is a Research Institute of the Biomedical Research Council under the Agency for Science, Technology and Research (A*STAR) in Singapore. As a Research institute, with a multidisciplinary team of biologists, physiologists, chemists, physicists, electrical/electronic engineers, computer scientists and clinicians, SBIC investigates human diseases which are major public health issues using molecular physiology and advanced bioimaging tools, in a translational and pivotal mode with the medical community and industrial partners (MNCs and SMEs). SBIC also works on strategic bioimaging projects, including the development of novel imaging probes. As a National Consortium, SBIC aims to harness and coordinate existing imaging expertise and capabilities in Singapore, bringing together substantial strengths in the physical sciences and engineering with those in the biomedical and clinical sciences. SBIC has built up an extensive network of partners, through collaborations and joint appointments with research institutes, university and clinical departments, and the industry – including the Singapore Institute for Clinical Sciences, National Skin Centre (Singapore), Duke-NUS, Bruker, Nikon, Danone, and iThera.
About Agency for Science, Technology and Research (A*STAR)A*STAR is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society.About the Singapore Bioimaging Consortium (SBIC)The Singapore Bioimaging Consortium (SBIC) is a Research Institute of the Biomedical Research Council under the Agency for Science, Technology and Research (A*STAR) in Singapore. As a Research institute, with a multidisciplinary team of biologists, physiologists, chemists, physicists, electrical/electronic engineers, computer scientists and clinicians, SBIC investigates human diseases which are major public health issues using molecular physiology and advanced bioimaging tools, in a translational and pivotal mode with the medical community and industrial partners (MNCs and SMEs). SBIC also works on strategic bioimaging projects, including the development of novel imaging probes. As a National Consortium, SBIC aims to harness and coordinate existing imaging expertise and capabilities in Singapore, bringing together substantial strengths in the physical sciences and engineering with those in the biomedical and clinical sciences. SBIC has built up an extensive network of partners, through collaborations and joint appointments with research institutes, university and clinical departments, and the industry – including the Singapore Institute for Clinical Sciences, National Skin Centre (Singapore), Duke-NUS, Bruker, Nikon, Danone, and iThera.
About Agency for Science, Technology and Research (A*STAR)A*STAR is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society.About the Singapore Bioimaging Consortium (SBIC)The Singapore Bioimaging Consortium (SBIC) is a Research Institute of the Biomedical Research Council under the Agency for Science, Technology and Research (A*STAR) in Singapore. As a Research institute, with a multidisciplinary team of biologists, physiologists, chemists, physicists, electrical/electronic engineers, computer scientists and clinicians, SBIC investigates human diseases which are major public health issues using molecular physiology and advanced bioimaging tools, in a translational and pivotal mode with the medical community and industrial partners (MNCs and SMEs). SBIC also works on strategic bioimaging projects, including the development of novel imaging probes. As a National Consortium, SBIC aims to harness and coordinate existing imaging expertise and capabilities in Singapore, bringing together substantial strengths in the physical sciences and engineering with those in the biomedical and clinical sciences. SBIC has built up an extensive network of partners, through collaborations and joint appointments with research institutes, university and clinical departments, and the industry – including the Singapore Institute for Clinical Sciences, National Skin Centre (Singapore), Duke-NUS, Bruker, Nikon, Danone, and iThera.